Experimental studies have shown that exposure to both single and repeated doses of DTIC could select for a more aggressive melanoma phenotype through induction of VEGF and interleukin 8 by mechanisms other than HSP27 [49]. This evidence concerns the gene CXCL8 and melanoma.